Cover Image
市場調查報告書

軟骨肉瘤:全球臨床實驗檢討

Chondrosarcoma Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 297514
出版日期 內容資訊 英文 105 Pages
訂單完成後即時交付
價格
Back to Top
軟骨肉瘤:全球臨床實驗檢討 Chondrosarcoma Global Clinical Trials Review, H1, 2014
出版日期: 2014年03月12日 內容資訊: 英文 105 Pages
簡介

本報告提供軟骨肉瘤的治療藥相關臨床實驗調查分析,提供臨床實驗數及被實驗人數,Phase別及各方面狀況,有潛力的企業,正在開發的治療藥的資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中·南美的主要國家

G7各國的臨床實驗:腫瘤科臨床實驗中軟骨肉瘤的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:階段別

E7各國的臨床實驗:腫瘤科臨床實驗中軟骨肉瘤的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:階段別

各方面的臨床實驗

Phase別臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與軟骨肉瘤治療藥臨床實驗的主要企業

有前途藥物

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Infinity Pharmaceuticals, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Agios Pharmaceuticals, Inc.
    • AEterna Zentaris Inc.
    • ACORN Research, LLC
  • 主要大學·研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Southwest Oncology Group
    • The University of Texas M. D. Anderson Cancer Center
    • Massachusetts General Hospital
    • Memorial Sloan Kettering Cancer Center
    • Radiation Therapy Oncology Group
    • Roswell Park Cancer Institute
    • University of Washington
    • Stanford University

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2026CTIDB

GlobalData's clinical trial report, "Chondrosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Chondrosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chondrosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chondrosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Chondrosarcoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Chondrosarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Chondrosarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Chondrosarcoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Chondrosarcoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Chondrosarcoma
    • Jun 18, 2012: Infinity Pharma Stops Phase II Trials Of Saridegib In Chondrosarcoma And Myelofibrosis
    • Oct 17, 2011: Infinity Provides Update On Phase II Trial Of IPI-926 In Chondrosarcoma
    • Jun 13, 2011: Arizona Oncology Enrolls Patients In Phase II Clinical Trial Of IPI-926 In Patients With Chondrosarcoma
    • Apr 03, 2011: Infinity Reports New Preclinical Data For IPI-926 At AACR Supporting Development In Chondrosarcoma
    • Mar 23, 2011: Infinity To Present New Preclinical Data On IPI-926 At Upcoming AACR Meeting
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Infinity Pharmaceuticals, Inc.
      • Clinical Trial Overview of Infinity Pharmaceuticals, Inc.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Agios Pharmaceuticals, Inc.
      • Clinical Trial Overview of Agios Pharmaceuticals, Inc.
      • AEterna Zentaris Inc.
      • Clinical Trial Overview of AEterna Zentaris Inc.
      • ACORN Research, LLC
      • Clinical Trial Overview of ACORN Research, LLC
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Southwest Oncology Group
      • Clinical Trial Overview of Southwest Oncology Group
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Radiation Therapy Oncology Group
      • Clinical Trial Overview of Radiation Therapy Oncology Group
      • Roswell Park Cancer Institute
      • Clinical Trial Overview of Roswell Park Cancer Institute
      • University of Washington
      • Clinical Trial Overview of University of Washington
      • Stanford University
      • Clinical Trial Overview of Stanford University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Chondrosarcoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Chondrosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chondrosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Chondrosarcoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Chondrosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chondrosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Chondrosarcoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Chondrosarcoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Chondrosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Chondrosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chondrosarcoma Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Chondrosarcoma Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chondrosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Agios Pharmaceuticals, Inc., 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AEterna Zentaris Inc., 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ACORN Research, LLC, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*

List of Figures

  • Chondrosarcoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Chondrosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chondrosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Chondrosarcoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Chondrosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chondrosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Chondrosarcoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Chondrosarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Chondrosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chondrosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chondrosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top